Vimarsana.com

supernus pharmaceuticals: Live & Latest News Updates : Vimarsana.com

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc.  .  Such investors are advised to contact Danielle Peyton at...

Paris
France-general-
France
Tel-aviv
Israel
London
City-of
United-kingdom
New-york
United-states
Chicago
Illinois

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc.

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN)....

Chicago
Illinois
United-states
Tel-aviv
Israel
New-york
Paris
France-general-
France
London
City-of
United-kingdom

Meritage Portfolio Management Has $1.24 Million Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Meritage Portfolio Management Has $1.24 Million Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Texas
United-states
Piper-sandler
Padmanabhp-bhatt
Supernus-pharmaceuticals-inc
Mystic-asset-management-inc
News-ratings-for-supernus-pharmaceuticals-daily
Supernus-pharmaceuticals-price-performance
Assetmark-inc
Nasdaq
China-universal-asset-management-co

FDA Decision on Apomorphine Infusion Device Delayed Again

The drug/device combination therapy provides a continuous subcutaneous infusion of apomorphine through an infusion pump. The FDA has issued a Complete Response Letter to Supernus Pharmaceuticals regarding the New Drug Application for SPN-830.

Jack-khattar
Drug-administration
Supernus-pharmaceuticals
Complete-response-letter
New-drug-application

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Jack-khattar
Tim-dec
Peter-vozzo
Timothyc-dec
Jacka-khattar
Nasdaq
Supernus-pharmaceuticals-to-announce-first-quarter
Supernus-pharmaceuticals-inc
Company-investor-relations
Supernus-pharmaceuticals
Announce-first-quarter
Host-conference-call

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tim-dec
Jack-khattar
Jacka-khattar
Peter-vozzoicr-westwicke
Timothyc-dec
Supernus-pharmaceuticals
Supernus-pharmaceuticals-inc
Nasdaq
Company-investor-relations
Cfosupernus-pharmaceuticals-inc
Senior-vice-president
Investor-relations

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tel-aviv
Israel
London
City-of
United-kingdom
Paris
France-general-
France
New-york
United-states
Chicago
Illinois

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc.

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN)....

Tel-aviv
Israel
Paris
France-general-
France
Chicago
Illinois
United-states
London
City-of
United-kingdom
New-york

Rx Rundown: Vertex Pharmaceuticals, Bristol Myers Squibb, Novartis and more

Rx Rundown: Vertex Pharmaceuticals, Bristol Myers Squibb, Novartis and more
mmm-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mmm-online.com Daily Mail and Mail on Sunday newspapers.

Florida
United-states
Alachua
California
United-kingdom
Spain
Times-square
Spanish
British
Moonlake-immunotherapeutics
Daiichi-sankyo
Geoff-curtis

Reuters Health News Summary

Reuters Health News Summary
devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.

Germany
Arizona
United-states
Switzerland
Swiss
Ankur-dhingra
Supernu-parkinson
Thomas-oxley
Joydeep-goswami
Synchron-inc
Supernus-pharmaceuticals
National-health-service

vimarsana © 2020. All Rights Reserved.